Cost analysis applied to postoperative analgesia regimens: A comparison between parecoxib and propacetamol

Pharmacy World and Science

Volumn 29, Issue 4, 2007, Pages 374-379

  Tilleul, P ^a   Weickmans, H ^a   Sean, P Tan ^a   Lienhart, A ^a   Beaussier, M ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Analgesics; Cost effectiveness; Parecoxib; Postoperative pain; Propacetamol; Surgery

Indexed keywords

MORPHINE; PARECOXIB; PROPACETAMOL;

ADULT; ANALGESIA; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; FEMALE; HERNIOPLASTY; HERNIORRHAPHY; HUMAN; INGUINAL HERNIA; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PATIENT SATISFACTION; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; TREATMENT OUTCOME;

ACETAMINOPHEN; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COST-BENEFIT ANALYSIS; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HERNIA, INGUINAL; HUMANS; INJECTIONS, INTRAVENOUS; ISOXAZOLES; MALE; MIDDLE AGED; MORPHINE; PAIN, POSTOPERATIVE; PATIENT SATISFACTION; PROSPECTIVE STUDIES;

EID: 34547562040     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-006-9083-x     Document Type: Article

References (29)

1. White PF. The role of non-opioid analgesic techniques in the management of pain after ambulatory surgery. Anesth Analg 2002;94:577-85.
2. Zhao SZ, Chung F, Hanna DB et al. Dose-response relationship between opioid use and adverse effects after ambulatory surgery. J Pain Symptom Manag 2004;28:35-46.
3. Rawal N, Hylander J, Nydhal PA et al. Survey of postoperative analgesia following ambulatory surgery. Acta Anaesth Scand 1997;41:1017-22.
4. Song D, Greilich NB, White PF et al. Recovery profiles and costs of anesthesia for outpatient unilateral inguinal herniorrhaphy. Anesth Analg 2000;91:876-81.
5. Cheer SM, Goa KL. Parecoxib (parecoxib sodium). Drugs 2001;61:133-43.
6. Gilron I, Milne B, Hong M. Cyclooxygenase-2 inhibitors in postoperative pain management: current evidence and future directions. Anesthesiology 2003;99:1198-208.
7. Leese PT, Talwalker S, Kent JD, Recker DP. Valdecoxib does not impair platelet function. Am J Emerg Med 2002; 20: 275-81.
8. Depre M, Van Hecken A, Verbesselt R et al. Tolerance and pharmacokinetics of propacetamol. a paracetamol formulation for intravenous use. Fund Clin Pharmacol 1992;6:259-62
9. Beaussier M, Weickmans H, Paugam C et al. Randomized double blind comparison between parecoxib sodium and propacetamol for parenteral postoperative analgesia after inguinal hernia repair in adult patients. Anesth Analg 2005;100:1309-15.
10. Kranke P, Morin A, Roewer N et al. Patient global evaluation of analgesia and safety for injected parecoxib for postoperative pain: A quantitative systematic review. Anesth Analg 2004;99:797-806.
11. Cook R, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310:452-54.
12. Laupacis A, Sackett DL. Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318:1728-33.
13. Carpenter J, Bithel J. Bootstraps confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med 2000;19:1141-64.
14. Macario A, Vitez T, Dunn B et al. Where are the costs in perioperative care? Analysis of hospital costs and charges for inpatient surgical care. Anesthesiology 1995;83:1138-44.
15. Macario A, McCoy M. The pharmacy cost of delivering postoperative analgesia to patients undergoing joint replacement surgery. J Pain 2003;4:22-28.
16. D'Hease J, Vanlesberghe C, Umbrain V et al. Pharmacoeconomic of a disposable patient-controlled analgesia device and intramuscular analgesia in surgical patients. Eur J Anaesth 1998;15:297-303.
17. Schuster M, Gottschalk A, Freitag M et al. Cost drivers in patient-controlled epidural analgesia for postoperative pain management after major surgery. Anaesth Analg 2004;98:708-13.
18. White PF. The changing role of non-opioid analgesic techniques in the management of postoperative pain. Anesth Analg 2005;1001(5 Suppl):S5-S22.
19. Watcha MF, White PF. Economics of anesthetic practice. Anesthesiology 1997; 86:1170-96.
20. Engoren M. Cost-effectiveness of different postoperative analgesic treatments. Expert Opin Pharmacother 2003;4:1507-19.
21. Daniels SE, Grossman EH, Kuss ME et al. A double blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model. Clin Ther 2001;23:1018-31.
22. Hubbard RC, Naumann TM, Traylor L et al. Parecoxib sodium has opioid sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia. Br J Anaesthes 2003;90:166-72.
23. Malan TP, March G, Hakki SI et al. Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing effect following total hip arthroplasty. Anesthesiology 2003;98:950-6.
24. Ng A, Smith G, Davidson AC. Analgesic effects of parecoxib following total abdominal hysterectomy. Br J Anaesthes 2003;90:746-9.
25. Ott E, Nusmeier NA, Duke PC, Feneck RO et al. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2003;125:1481-92.
26. Barton SF, Langeland FF, Snabes MC et al. Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery. Anesthesiology. 2002;97:306-14.
27. Lauritsen J, Moller A. Publications in anesthesia journals: quality and clinical relevance. Anesth Analg 2004;99:1486-91.
28. Watcha MF, Issioui T, Klein KW et al. Cost and effectiveness of rofecoxib. celecoxib and acetaminophen for preventing pain after ambulatory otolaryngologic surgery. Anesth Analg 2003;96:987-94.
29. Issioui T, Klein KW, White PF et al. Cost-efficacy of rofecoxib versus acetaminophen for preventing pain after ambulatory surgery. Anesthesiology 2002;974:931-7.